Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ZILLOW GROUP, INC. Director's Dealing 2021

Feb 20, 2021

30299_dirs_2021-02-19_b46a95b0-aa51-4f58-9b32-302d4deeb525.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZILLOW GROUP, INC. (Z AND ZG)
CIK: 0001617640
Period of Report: 2021-02-17

Reporting Person: Johnson Aimee (Chief Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-17 Class C Capital Stock S 100.0000 $191.7400 Disposed 55216.0000 Direct
2021-02-17 Class C Capital Stock S 101.0000 $190.6982 Disposed 55115.0000 Direct
2021-02-17 Class C Capital Stock S 400.0000 $189.8225 Disposed 54715.0000 Direct
2021-02-17 Class C Capital Stock S 576.0000 $188.3854 Disposed 54139.0000 Direct
2021-02-18 Class C Capital Stock M 5688.0000 $29.0900 Acquired 59827.0000 Direct
2021-02-18 Class C Capital Stock M 3384.0000 $40.3600 Acquired 63211.0000 Direct
2021-02-18 Class C Capital Stock S 12375.0000 $183.4661 Disposed 50836.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-18 Stock Option (Right to Buy) $40.3600 M 3384.0000 Disposed 2029-03-01 Class C Capital Stock (3384.0000) Direct
2021-02-18 Stock Option (Right to Buy) $29.0900 M 5688.0000 Disposed 2028-12-20 Class C Capital Stock (5688.0000) Direct

Footnotes

F1: Represents shares sold to cover tax withholding due upon vesting of restricted stock units.

F2: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $190.69 to $191.52. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $189.41 to $190.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $187.96 to $188.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: 7,585 shares of the reported balance represents a grant of restricted stock units that vested as to 1/4th of the total amount of shares subject to the grant on November 26, 2019 and an additional 1/16th shall become vested on each issuer quarterly vesting date occurring thereafter until the restricted stock units are fully vested. 1,266 shares of the reported balance represents a grant of restricted stock units that vested as to 1/16th of the total amount of shares subject to the grant, respectively on each of May 15, 2019, August 14, 2019 and November 13, 2019 and an additional 1/16th shall become vested on each issuer quarterly vesting date occurring thereafter until the restricted stock units are fully vested.

F6: The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $183.2737 to $183.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.

F7: Date at which first vesting occurs us indicated. 1/16th of the total number of shares subject to the option become exercisable at the first vesting date and an additional 1/16th become exercisable on each issuer quarterly vesting date occurring thereafter until the option is fully vested.

F8: Date at which first vesting occurs is indicated. 1/4th of the total number of shares subject to the option become exercisable at the first vesting date and an additional 1/16th become exercisable on each issuer quarterly vesting date occurring thereafter until the option is fully vested.